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The hippocampus plays important roles in the regulation and combination of short and long term
memory and spatial navigation with other brain centers. Aging is accompanied by a functional decline of
the hippocampus and degenerative disease. Microglia are major immune cells in the central nervous
system and response to degenerative changes in the aged brain. In this respect, functional and
morphological changes of the hippocampus have been closely related to microglial changes during
normal aging with or without disease. Therefore, in this review, we discuss morphological and functional
changes of the hippocampus and microglia in the aging brain.
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Aging is accepted worldwide in social and political agendas
as well as in research agendas. Functional declines in various
organ systems including the central nervous system (CNS)
are associated with normal aging processes. Aging in the brain
is a major risk factor for increases in neurodegenerative diseases
such as Alzheimer’s and Parkinson’s diseases [1,2]. Most
functional changes in the CNS with normal aging are associated
with a decline in learning and memory. It is well accepted
that the hippocampus is a very important region related to
learning and memory because the hippocampus is connected
to other brain regions that are related to learning and memory
[3-6]. The hippocampus is also known as the most vulnerable
region affected by the internal and external changes of normal
aging, and with strokes and other neurodegenerative diseases
[7-10]. The functional decline of the CNS, including the
hippocampus, with normal aging and degenerative processes
is accompanied by changes in the number and function of
neurons and glia, their volumes, and various factors such
as neurotransmitters, hormones, oxidative stress and
inflammation [2,11,12].
There is no doubt that microglial change in the CNS is
associated primarily or secondarily with neurodegenerative
diseases in the aged brain [13,14]. Microglia, which are
immune cells, account for 5-20% of the total glial cell
population in the CNS and are evenly distributed throughout
the brain parenchyma. They respond rapidly to a variety
of alterations in the microenvironment of the brain and act
as a sensor for pathological events in the brain [15,16].
Numerous studies and reviews have reported that numerical,
morphological and functional changes in microglia are
apparently changed in the normal aging brain and in the
aged brain with diseases [1,2,6,12,17-21]. In this review, we
discuss the literature on age-related changes in microglia in
the hippocampus.
Structure and Function of the 
Hippocampus
The hippocampus is one of the oldest brain regions
phylogenetically. It consists of two major parts: the
hippocampus proper (Ammon’s horn or cornu ammonis, CA)
and the dentate gyrus (DG). The hippocampus proper contains
three sub-regions (regions CA1-CA3), and each subregion
consists of 3 distinct layers: stratum oriens (SO), stratum
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pyramidale (SP) and stratum radiate (SR) (from the outermost
to the innermost). Main excitatory output neurons referred
to as pyramidal neurons are located in the SP [22]. The
hippocampus is involved in various physiological functions
such as olfaction, arousal, cognition, learning and memory
[4,23,24].
Extensive work on hippocampal function associated with
memory is still ongoing [25-28]. Although controversy on the
exact functional role of the hippocampal sub-region is ongoing,
the CA1 region appears to be related with the association
and completion of temporal patterns as well as intermediate-
term memory. The CA3 region mediates processes related
with spatial pattern association and completion as well as
short-term memory [4,26,28-31]. Although the DG is a main
subregion of the hippocampus, its function also needs to
be studied more; the DG is involved in metric spatial
representation and spatial pattern separation [23,24,28].
Aging Hippocampus
Age-related losses of hippocampal volume and neuronal
number in the aged hippocampus have been reported
[7,18,32-35]. Early studies showed that a significant neuronal
loss in the CA1 region is correlated with aging in the human
hippocampus, not in other hippocampal regions [32,36]. In
addition, pyramidal neurons are significantly decreased in
the SP of the CA1 and CA3 regions of the hippocampus
in both cognitively impaired and unimpaired rats [33]. Later,
however, the same researchers and others reported that the
number of hippocampal neurons with aging is relatively
persistent in primates and rodents during normal aging using
different methods [7,34,35]. These studies proposed that early
studies, which showed that neuronal loss happens in the
aged hippocampus, had some errors in their methods,
sampling and pathological conditions. Many other researchers
have confirmed that neuronal loss in the normally aged
hippocampus is not characteristic of this brain region [5,37-
39]. However, a marked neuronal loss in the aged
hippocampus occurs in some degenerative conditions such
as Alzheimer’s disease and experimental autoimmune
encephalomyelitis [5,7,10,32,40].
On the other hand, a reduction in hippocampal volume
with aging has been found in primates and rodents using
histological studies [30,31,41]. Recently, many researchers
have confirmed age-related decreases in the volume of the
hippocampus using magnetic resonance imaging in primates
and rodents [42-44]. Nowadays, therefore, it is well accepted
that normal aging is accompanied by hippocampal shrinkage,
and hippocampal shrinkage is closely related to functional
decline in learning and memory in the aged brain. Various
groups have tried to elucidate substrates of age-related
hippocampal learning and memory deficits and have focused
on neurobiological alterations as follows.
One of major finding in the literature is a change in synaptic
plasticity of hippocampal neurons that present as long term
potentiation and long term depression. It has been reported
that no significant changes in dendritic regression are observed
in the CA regions and subiculum, and, in the DG, dendritic
extent is increased in the aged rat and human [45-47]. In
addition, the spinal density of hippocampal neurons in the
DG and CA1 region is not significantly changed in the aged
human and rat [46,48,49]. Furthermore, biophysical properties
of CA pyramidal cells or DG granule cells are mostly preserved
in the normally aging hippocampus compared to those in
the young hippocampus [6,18,50]. However, perforating
synaptic contacts, especially presynaptic fibers, decrease in
the DG of aged rats [51,52]. In addition, the density of
fragmented axons, which project from various brain regions
into the hippocampus, increases in the aged hippocampus [53].
On the other hand, there are many studies that show that
noradrenergic, dopaminergic, serotonergic and cholinergic
projecting fibers decrease in the aging hippocampus [29,54-
56]. Other studies have focused on changes in the aged
hippocampus in cellular substrates such as ions, hormones,
neurotrophic factors and biomolecules. A role for
glucocorticoids in neuronal aging in the hippocampus (the
glucocorticoid cascade hypothesis) has been suggested by
some researchers [9,57,58]. Starting with these studies,
extensive studies have shown that, in the aging hippocampus,
glucocorticoids and stress contribute to learning and memory
function deficits in the aging hippocampus [19,21,59].
Many researchers have found correlations of hippocampal
functional decline with changes in ions such as calcium,
potassium and magnesium conductance in aged neurons
[60,61]. For example, calcium conduction and the number
of L-type calcium channels increase significantly in hippocampal
CA1 and CA3 neurons of the aged rat and rabbit [62-65].
Other studies have reported that magnesium deficiency in
the aged hippocampus impairs learning and memory function
[66-68]. These studies suggest that the dysregulation of cation
homeostasis might be a major cause of deficits in learning
and memory in the aged hippocampus.
Brain-derived neurotrophic factor (BDNF) is implicated in
age-related hippocampal function [69]. Many studies have
reported that BDNF and the BDNF-TrkB system decrease
with aging in human, monkey and rodent hippocampus [70-
72]. The decline of BDNF levels in the hippocampus can
cause an impairment in long-term potentiation in the agedMicroglia in aged hippocampus 183
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rat [73].
Recently, a few studies on changes in cellular substrates
in the aging hippocampus have been done using proteomic
analysis [3,74,75]: Broad changes in proteins focused on
various processes such as glucose metabolism, oxidative stress,
signal transduction, protein folding and neurotransmitter
release and synaptic signaling in the aged hippocampus have
been conducted. These studies have provided evidence for
functional declines in these processes with aging.
Microglia in the Hippocampus
In the CNS, microglia are classified into ameboid,
intermediate, ramified (resting), activated and phagocytic,
depending on their morphology under normal and disease
conditions [76-78]. During early postnatal development,
ameboid microglia migrate and proliferate in the brain
parenchyma, and are transformed into ramified microglia in
the adult brain by transforming into intermediate microglia
with elongated process or pseudopodia. Ramified microglia
are known as resting microglia and have a small oval soma
with numerous branched processes. These spread throughout
the entire brain and play an important role in brain homeostasis
under normal conditions. Ramified microglia are transformed
into activated microglia and/or phagocytic microglia via
reactive or primed microglia in response to certain pathological
conditions such as traumatic injury, ischemia and Alzheimer’s
disease (AD), which are accompanied by inflammation
[8,13,77,79-82].
The hippocampus is one region of the brain where dense
microglia present, like the olfactory bulb, telencephalon, basal
ganglia and substantia nigra [15]. Studies on the regional
distribution of microglia between various brain regions are
limited, and results are controversial [15,83-88]. An early study
reported that in the adult mouse hippocampus F4/80-
immunoreactive microglia in the DG are more numerous
than in Ammon’s horn [15]. Recently, the microglial distribution
in the hippocampus has been reported using different
stereological methods [83-86]. These studies show that
microglial density in the CA1 region is higher than in the
DG, although the total microglial number is also different.
Using immunohistochemistry with ionized calcium-binding
adapter molecule 1, Jino et al (2007) found that in the mouse
hippocampus microglial density in the CA3 region is lower
than in the CA1 region and the DG, and the density of
microglia in the CA1 is higher than in the DG [87]. They
suggested that microglial density might be involved in site-
specific vulnerability of the hippocampus, and that the
heterogeneous distribution of microglia would participate in
the modulation of hippocampal neuronal activity [88].
Microglia in the Aging 
Hippocampus
Only a small number of studies have focused on microglial
distribution and total number in the hippocampus using
stereological methods [89-92], although a large number of
studies have been conducted in other brain regions under
normal and abnormal conditions. No age-related differences
in microglia were found in the aging hippocampus of male
mice [89,90]. However, the same research team reported
that the number of microglia is significantly increased in the
hippocampus of the same mouse strain [90]. In contrast, some
researchers found that the number of microglia is decreased
in the aged hippocampal CA1 region of the ICR mouse [91,92].
This discrepancy may be due to different animals or strains,
markers for microglia and stereological methods.
Although there is a lack of detailed studies on changes
in microglial number with aging, the change must be related
with functional changes with age. Actually, many studies show
that morphology and/or antigen expression in microglia are
changed in the aged hippocampus as well as in other brain
regions [8,82,92-98]. It is well known that the resting form
of microglia is transformed into the activated form of microglia
with aging [96,97]. Many studies have shown that the activated
form of microglia is increased in number in the aged monkey,
dog and rodent hippocampus as well as in the human
hippocampus [8,82,92-95]. These activated microglia show
high elevations of various antigens such as major
histocompatibility complex (MHC) antigens, interleukin-1α
(IL-1α), MHC class II cell surface receptor, Iba-1 and lectin
in the hippocampus [8,82,94,98,99].
Recently, a large number of studies on functional changes
in adult and aged microglia have been conducted with primed
microglia. The primed microglia, which was introduced by
Perry, have shortened processes with surface antigens such
as MHC II similar to those in activated microglia, and the
primed microglia are devoid of the ability to secrete pro-
inflammatory cytokines in the CNS [79-81]. Along with the
primed microglia concept, it has been suggested that the
functions of adult and aged microglia are different under
normal and pathological conditions [17,20,79,100,101].
Microglia cultured from aged brains express high basal IL-
6, and microglia more highly express IL-6 as well as IL-1β
after lipopolysaccharide treatment compared to microglia
cultured from adult brain [102,103]. In addition, aged microglia
show an exaggerated response to systemic inflammation
[79,100,101]: microglia in adult animal models of some types184 Jung Hoon Choi, Moo-Ho Won
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of inflammation produce an increase in anti-inflammatory
cytokines and fewer inflammatory cytokines. However,
microglia in middle-aged animals show a reversed production
of anti-inflammatory and inflammatory cytokines [103-105].
Consistent with these studies, emerging evidence suggests
that hippocampal functions after systemic infection are
accompanied by an increase in microglia activation, which
are more easily disrupted in aged rodents [98,100,103,105,
106]. Nevertheless, many researchers agree we still need to
examine further specific markers, methods and criteria to
define primed microglia and activated microglia as well as
resting microglia, because the morphology of primed microglia
show some features similar to activated microglia. In addition,
resting microglia and activated or phagocytic microglia also
express MHC II and Iba-1 in normal and pathological
conditions.
Microglial senescence represents a dystrophy with aging
[107]. In an in vitro study, was reported that morphological
degeneration of cultured microglia occurs after expose to
amyloid beta protein [108]. Streit and his colleague reported
that dystrophic microglia show a loss of fine branches
(deramification), shortened tortuous processes or cytoplasmic
fragmentation except for spheroid cytoplasm in the aged
human brain. They suggested that microglial dystrophy is a
sign of microglial senescence [107,109]. In addition, they
suggested, based on their data, that neurodegeneration may
occur secondarily after microglial senescence and that
neurodegeneration is associated with a loss of microglial
neuroprotective function. They also showed that dystrophic
(senescent) microglia rather than activated microglia likely
precede neurodegeneration in Alzheimer's disease [110]. In
addition, abnormal and degenerating microglia are detected
in other neurodegenerative diseases including amyotrophic
lateral sclerosis, Creutzfeldt–Jakob disease, Huntington’s
disease and schizophrenia [111-113]. They also suggested
that an increase in the number of activated microglia in the
brain with aging and neurodegenerative disease must be
reconsidered, because dystrophic microglia might have been
misidentified as activated microglia in previous studies. Other
groups have consistently provided evidence that microglial
senescence produces a shortened telomere and a decrease
in their activities in aging and neurodegenerative disease [114-
117]. However, to the best of our knowledge, there is no
study that has focused in detail on dystrophic changes of
microglia in the hippocampal subregions with normal aging,
although some studies have shown dystrophic changes in
microglia in the parahippocampal cortex [107,110,115,117].
Further studies on the stereological classification of microglia
combined with primed and dystrophic microglia could identify
the region-specific functions of microglia in the aged
hippocampus.
Conclusion
The most distinctive age-related change in the hippocampus
is a decrease in its volume with a reduction in the number
of projecting fibers from other related brain regions. No
significant loss of hippocampal neurons occurs with aging.
With the volume change, many cellular substrates also
markedly change in the aging hippocampus. Stereological
studies on the total or region-specific number of primed and
dystrophic microglia should be done in the aged hippocampus.
In addition, there are some controversies about on major
microglial functions that are harmful or beneficial for the patient
undergoing degenerative changes in the aged brain. However,
in the aged hippocampus the majority of functional declines
with aging are closely related to morphological and functional
changes of microglia.
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